Clinical Trial Update: Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (ECTOP-1012) evaluating segmentectomy for ground-glass-dominant invasive lung cancer is currently recruiting. The trial is sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Snippet

Sponsor: Fudan University | Conditions: Segmentectomy, Lung Adenocarcinoma | Phase 3 | Status: RECRUITING